ClearPoint Neuro, Inc. (CLPT) Profit Margins
Over the twelve months to 2026-06-30, ClearPoint Neuro, Inc. (CLPT) had gross margin 62.6%, operating margin -73.4%, net margin -81.8%, free cash flow margin -74.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLPTClearPoint Neuro, Inc.Follow CLPT — free
—
Price chart with a free account
- Market cap
- 278.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
| Line | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 89.0% | 63.8% | 46.5% | 56.7% | 54.0% | 60.7% | 66.9% | 64.9% | 71.1% | 68.2% | 65.8% | 56.8% | 60.9% | 61.4% | 62.6% | |
| Operating margin | -61.9% | -190.2% | -147.6% | -195.3% | -130.3% | -85.9% | -71.4% | -41.0% | -48.5% | -82.1% | -79.5% | -93.7% | -62.9% | -65.4% | -73.4% | |
| Net margin | -116.2% | -180.3% | -125.5% | -183.9% | -140.4% | -97.1% | -83.8% | -49.4% | -52.9% | -88.4% | -80.0% | -92.2% | -60.3% | -69.1% | -81.8% | |
| FCF margin | -149.5% | -199.8% | -202.5% | -189.7% | -103.0% | -81.6% | -63.8% | -25.5% | -61.2% | -78.9% | -79.9% | -60.3% | -29.4% | -66.1% | -74.0% |
USD millions · SEC XBRL
ClearPoint Neuro, Inc. — questions
- What is ClearPoint Neuro, Inc.'s gross margin?
- 62.6% over the twelve months to 2026-06-30.
- What is ClearPoint Neuro, Inc.'s operating margin?
- -73.4% over the twelve months to 2026-06-30.
- What is ClearPoint Neuro, Inc.'s net profit margin?
- -81.8% over the twelve months to 2026-06-30.
Every figure on this page comes from ClearPoint Neuro, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.